New York, NY — (SBWIRE) — 03/03/2017 — Animal Drug Compounding Market: Drivers and Challenges
The growth of veterinary drug compounding market is mainly driven by the increasing number of pets and growing adoption of compounded drugs to increase animal compliance with flavoring alternatives and route of administration. Currently, many drugs are approved for animal treatment. However, these are still many different species with different rare diseases conditions for which there are no FDA-approved drugs available. To overcome this issue many approved human drugs are used for the treatment of the animal with the help of drug compounding, for example, several approved chemotherapeutic drugs are used to treat cancer in dogs and cats. Moreover, the emergence of veterinary specialties such as oncology, cardiology, and neurology, and the growth of veterinary referral centers is expected to drive the need for compounded medications. The growing trend of pet adoption is expected to boost the veterinary drug compounding market. In Japan, the companion dog population has increased to approximately 12.5 million and cats have increased up to 11.6 million. Similarly, in Australia, the companion dog population has increased to 3.75 million, cats up to 2.43 million, and other animals such as birds, rodents, and fish has increased to 32.9 million other animals.
Animal Drug Compounding Market: Key Players
Some of the key players in veterinary drug compounding market are Sanofi-Aventis, Novartis, Fagron, Pfizer Inc., Essential Pharmacy Compounding, Triangle Compounding Pharmacies, and Lorraine’s Pharmacy among others.
Animal Drug Compounding Market: Regional Overview
Based on geographic region, veterinary drugs compounding market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. North America holds the largest revenue share in the veterinary drugs compounding market followed by Europe owing to well-established animal healthcare market and growing number of veterinary practitioners etc. Asia-Pacific is expected to grow at the fastest CAGR owing to the growing trend of pet animals especially in China and India. Moreover, increasing the focus of pet owners towards the animal health and safety have boosted the growth for veterinary drugs compounding market.
Browse Full Report summary and to request sample report and table of content@ http://www.persistencemarketresearch.com/market-research/animal-drug-compounding-market.asp